Anna comes to CTI with more than 30 years of experience in the pharmaceutical and clinical research industry. Most recently, prior to joining CTI, Anna served as Vice President, Clinical Trial Operations at a mid-size global CRO, where she directed the Clinical Trial Operations North American division of the company and managed cross-global studies. Throughout her career, Anna has also gained experience as a clinical nurse specializing in Neurosurgery and NICU, a CRA, a GCP auditor, and a patient and site recruiter. Anna received a Bachelor’s degree in Psychology and her BSN from Emory University. She also earned an MBA from Golden Gate University.
In her role as VP Global Clinical Monitoring, Anna will manage and oversee the Clinical Monitoring function at CTI, managing team members working in more than 40 countries around the world.
“We are thrilled to welcome Anna to CTI’s clinical group,” remarks Kevin Schwarz, Chief Operating Officer. “Her extensive and varied leadership experience in the health and pharmaceutical industry will be a significant asset to the growing team at CTI.”